Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Amortizatization of Intangibles (2023 - 2025)

Historic Amortizatization of Intangibles for Immunocore Holdings (IMCR) over the last 3 years, with Q3 2025 value amounting to $567000.0.

  • Immunocore Holdings' Amortizatization of Intangibles rose 1618.85% to $567000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 2526.55%. This contributed to the annual value of $1.9 million for FY2024, which is 1608.99% up from last year.
  • Per Immunocore Holdings' latest filing, its Amortizatization of Intangibles stood at $567000.0 for Q3 2025, which was up 1618.85% from $568000.0 recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Amortizatization of Intangibles registered a high of $568000.0 during Q2 2025, and its lowest value of $401000.0 during Q2 2023.
  • Its 3-year average for Amortizatization of Intangibles is $476363.6, with a median of $437000.0 in 2023.
  • As far as peak fluctuations go, Immunocore Holdings' Amortizatization of Intangibles soared by 614.25% in 2024, and later surged by 3148.15% in 2025.
  • Quarter analysis of 3 years shows Immunocore Holdings' Amortizatization of Intangibles stood at $437000.0 in 2023, then increased by 28.15% to $560000.0 in 2024, then rose by 1.25% to $567000.0 in 2025.
  • Its Amortizatization of Intangibles stands at $567000.0 for Q3 2025, versus $568000.0 for Q2 2025 and $546000.0 for Q1 2025.